Literature DB >> 24631136

MADP, a salidroside analog, protects hippocampal neurons from glutamate induced apoptosis.

Hua Xian1, Jing Zhao2, Yuan Zheng2, Meihong Wang2, Jun Huang3, Bingxin Wu3, Cheng Sun4, Yumin Yang5.   

Abstract

AIMS: To investigate the anti-apoptotic effect of MADP, an analog of salidroside, against glutamate induced apoptosis in the cultured rat hippocampal neurons. MAIN
METHODS: Cytotoxicity was determined by the MTT method and lactate dehydrogenase release to the medium. Cell apoptosis was evaluated by Hoechst 33342 staining, TUNEL assay and flow cytometric analysis. Western blotting was applied for detecting protein levels of cellular signaling molecules. KEY
FINDINGS: Our results showed that glutamate exposure significantly induces cell apoptosis, whereas the pretreatment of salidroside or MADP remarkably improves cell viability. Most importantly, the anti-apoptotic effect of MADP against glutamate insult is superior to salidroside. To explore the involved mechanisms, we measured some pro-apoptotic and anti-apoptotic protein levels, and several cell survival signaling pathways were analyzed as well. No visible alterations in Bcl-2 and Bax protein levels were observed by MADP or salidroside. Akt and JNK phosphorylation was robustly stimulated by MADP in the glutamate-treated neurons. Salidroside treatment results in a slight activation in Akt, while no significant alteration in JNK activity was observed. SIGNIFICANCE: MADP exhibits higher capacity to attenuate glutamate induced cell apoptosis in the cultured rat hippocampal neurons, suggesting that MADP might be a better candidate than salidroside for developing novel drugs treating neuron loss associated disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Glutamate excitotoxicity; Hippocampal neurons; Neurodegeneration; Salidroside analog

Mesh:

Substances:

Year:  2014        PMID: 24631136     DOI: 10.1016/j.lfs.2014.02.040

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer's disease models.

Authors:  Bei Zhang; Ying Wang; Hui Li; Ran Xiong; Zongbo Zhao; Xingkun Chu; Qiongqiong Li; Suya Sun; Shengdi Chen
Journal:  Drug Des Devel Ther       Date:  2016-04-06       Impact factor: 4.162

2.  Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer's disease.

Authors:  Bei Zhang; Qiongqiong Li; Xingkun Chu; Suya Sun; Shengdi Chen
Journal:  Transl Neurodegener       Date:  2016-11-29       Impact factor: 8.014

3.  Salidroside attenuates hypoxia/reoxygenation-induced human brain vascular smooth muscle cell injury by activating the SIRT1/FOXO3α pathway.

Authors:  Lina Xu; Longbin Jia; Qingyun Wang; Jing Hou; Shifang Li; Junfang Teng
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

4.  Conditioned Medium Derived from Salidroside-Pretreated Mesenchymal Stem Cell Culture Ameliorates Mouse Lipopolysaccharide-Induced Cerebral Neuroinflammation- Histological and Immunohistochemical Study.

Authors:  Zeinab M El Maadawi
Journal:  Int J Stem Cells       Date:  2017-05-30       Impact factor: 2.500

Review 5.  Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system.

Authors:  Zhifeng Zhong; Jing Han; Jizhou Zhang; Qing Xiao; Juan Hu; Lidian Chen
Journal:  Drug Des Devel Ther       Date:  2018-05-24       Impact factor: 4.162

6.  Salidroside improves glucose homeostasis in obese mice by repressing inflammation in white adipose tissues and improving leptin sensitivity in hypothalamus.

Authors:  Meihong Wang; Lan Luo; Lili Yao; Caiping Wang; Ketao Jiang; Xiaoyu Liu; Muchen Xu; Ningmei Shen; Shaodong Guo; Cheng Sun; Yumin Yang
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.